Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy

Elisabetta Riva; Ferdinando Dianzani; Guido Antonelli; Mauro Pistello; Pasquale Narciso; Gianpiero D'Offizi; Patrizia Isola; Vincenzo Galati; Ombretta Turriziani; Valerio Tozzi; Laura Vincenzi

doi:10.1089/088922201753342004

Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy

Elisabetta Riva, Ferdinando Dianzani, Guido Antonelli, Mauro Pistello, Pasquale Narciso, Gianpiero D'Offizi, Patrizia Isola, Vincenzo Galati, Ombretta Turriziani, Valerio Tozzi, Laura Vincenzi

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Research output: Contribution to journal › Article › peer-review

Abstract

The present study was aimed at describing the effect of highly active antiretroviral therapy (HAART) in 10 patients with primary HIV infection (PHI). Clearance rates of HIV RNA and HIV DNA in peripheral blood as well as the preexistence and the emergence of drug-resistant strains of HIV were determined over 52 weeks of treatment. The data indicate that HAART is able to induce a suppression of plasma viral load together with a significant decrease, but not a suppression, of peripheral blood mononuclear cell-associated proviral DNA in PHI subjects. Analysis of drug-resistant strains revealed that three PHI patients, showing a complete virologic response, developed mutations in the pol gene, thus suggesting that a persistent residual virus replication exists despite a sustained suppression of plasma viremia.

Original language	English
Pages (from-to)	1599-1604
Number of pages	6
Journal	AIDS Research and Human Retroviruses
Volume	17
Issue number	17
DOIs	https://doi.org/10.1089/088922201753342004
Publication status	Published - 2001

ASJC Scopus subject areas

Immunology
Virology

Access to Document

10.1089/088922201753342004

Fingerprint Dive into the research topics of 'Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy'. Together they form a unique fingerprint.

Cite this

Riva, E., Dianzani, F., Antonelli, G., Pistello, M., Narciso, P., D'Offizi, G., Isola, P., Galati, V., Turriziani, O., Tozzi, V., & Vincenzi, L. (2001). Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy. AIDS Research and Human Retroviruses, 17(17), 1599-1604. https://doi.org/10.1089/088922201753342004

Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy. / Riva, Elisabetta; Dianzani, Ferdinando; Antonelli, Guido; Pistello, Mauro; Narciso, Pasquale; D'Offizi, Gianpiero; Isola, Patrizia; Galati, Vincenzo; Turriziani, Ombretta; Tozzi, Valerio; Vincenzi, Laura.

In: AIDS Research and Human Retroviruses, Vol. 17, No. 17, 2001, p. 1599-1604.

Research output: Contribution to journal › Article › peer-review

Riva, E, Dianzani, F, Antonelli, G, Pistello, M, Narciso, P, D'Offizi, G, Isola, P, Galati, V, Turriziani, O, Tozzi, V & Vincenzi, L 2001, 'Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy', AIDS Research and Human Retroviruses, vol. 17, no. 17, pp. 1599-1604. https://doi.org/10.1089/088922201753342004

Riva, Elisabetta ; Dianzani, Ferdinando ; Antonelli, Guido ; Pistello, Mauro ; Narciso, Pasquale ; D'Offizi, Gianpiero ; Isola, Patrizia ; Galati, Vincenzo ; Turriziani, Ombretta ; Tozzi, Valerio ; Vincenzi, Laura. / Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy. In: AIDS Research and Human Retroviruses. 2001 ; Vol. 17, No. 17. pp. 1599-1604.

@article{6f8da29d36cc4dd483b03efd99e7e04e,

title = "Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy",

abstract = "The present study was aimed at describing the effect of highly active antiretroviral therapy (HAART) in 10 patients with primary HIV infection (PHI). Clearance rates of HIV RNA and HIV DNA in peripheral blood as well as the preexistence and the emergence of drug-resistant strains of HIV were determined over 52 weeks of treatment. The data indicate that HAART is able to induce a suppression of plasma viral load together with a significant decrease, but not a suppression, of peripheral blood mononuclear cell-associated proviral DNA in PHI subjects. Analysis of drug-resistant strains revealed that three PHI patients, showing a complete virologic response, developed mutations in the pol gene, thus suggesting that a persistent residual virus replication exists despite a sustained suppression of plasma viremia.",

author = "Elisabetta Riva and Ferdinando Dianzani and Guido Antonelli and Mauro Pistello and Pasquale Narciso and Gianpiero D'Offizi and Patrizia Isola and Vincenzo Galati and Ombretta Turriziani and Valerio Tozzi and Laura Vincenzi",

year = "2001",

doi = "10.1089/088922201753342004",

language = "English",

volume = "17",

pages = "1599--1604",

journal = "AIDS Research and Human Retroviruses",

issn = "0889-2229",

publisher = "Mary Ann Liebert Inc.",

number = "17",

}

TY - JOUR

T1 - Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy

AU - Riva, Elisabetta

AU - Dianzani, Ferdinando

AU - Antonelli, Guido

AU - Pistello, Mauro

AU - Narciso, Pasquale

AU - D'Offizi, Gianpiero

AU - Isola, Patrizia

AU - Galati, Vincenzo

AU - Turriziani, Ombretta

AU - Tozzi, Valerio

AU - Vincenzi, Laura

PY - 2001

Y1 - 2001

N2 - The present study was aimed at describing the effect of highly active antiretroviral therapy (HAART) in 10 patients with primary HIV infection (PHI). Clearance rates of HIV RNA and HIV DNA in peripheral blood as well as the preexistence and the emergence of drug-resistant strains of HIV were determined over 52 weeks of treatment. The data indicate that HAART is able to induce a suppression of plasma viral load together with a significant decrease, but not a suppression, of peripheral blood mononuclear cell-associated proviral DNA in PHI subjects. Analysis of drug-resistant strains revealed that three PHI patients, showing a complete virologic response, developed mutations in the pol gene, thus suggesting that a persistent residual virus replication exists despite a sustained suppression of plasma viremia.

AB - The present study was aimed at describing the effect of highly active antiretroviral therapy (HAART) in 10 patients with primary HIV infection (PHI). Clearance rates of HIV RNA and HIV DNA in peripheral blood as well as the preexistence and the emergence of drug-resistant strains of HIV were determined over 52 weeks of treatment. The data indicate that HAART is able to induce a suppression of plasma viral load together with a significant decrease, but not a suppression, of peripheral blood mononuclear cell-associated proviral DNA in PHI subjects. Analysis of drug-resistant strains revealed that three PHI patients, showing a complete virologic response, developed mutations in the pol gene, thus suggesting that a persistent residual virus replication exists despite a sustained suppression of plasma viremia.

UR - http://www.scopus.com/inward/record.url?scp=0035695104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035695104&partnerID=8YFLogxK

U2 - 10.1089/088922201753342004

DO - 10.1089/088922201753342004

M3 - Article

C2 - 11779347

AN - SCOPUS:0035695104

VL - 17

SP - 1599

EP - 1604

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 17

ER -